BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 26498716)

  • 1. Catheter ablation of atrial fibrillation in patients with diabetes mellitus: a systematic review and meta-analysis.
    Anselmino M; Matta M; D'ascenzo F; Pappone C; Santinelli V; Bunch TJ; Neumann T; Schilling RJ; Hunter RJ; Noelker G; Fiala M; Frontera A; Thomas G; Katritsis D; Jais P; Weerasooriya R; Kalman JM; Gaita F
    Europace; 2015 Oct; 17(10):1518-25. PubMed ID: 26498716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis.
    Anselmino M; Matta M; D'Ascenzo F; Bunch TJ; Schilling RJ; Hunter RJ; Pappone C; Neumann T; Noelker G; Fiala M; Bertaglia E; Frontera A; Duncan E; Nalliah C; Jais P; Weerasooriya R; Kalman JM; Gaita F
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1011-8. PubMed ID: 25262686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
    Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
    JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter Ablation vs. Anti-Arrhythmic Drugs as First-Line Treatment in Symptomatic Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Saglietto A; Gaita F; De Ponti R; De Ferrari GM; Anselmino M
    Front Cardiovasc Med; 2021; 8():664647. PubMed ID: 34095254
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis.
    Hakalahti A; Biancari F; Nielsen JC; Raatikainen MJ
    Europace; 2015 Mar; 17(3):370-8. PubMed ID: 25643988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
    Xu B; Peng F; Tang W; Du Y; Guo H
    Ann Pharmacother; 2016 Sep; 50(9):697-705. PubMed ID: 27317015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Need for ongoing anti arrhythmic drugs after ablation of atrial fibrillation. Review.
    Salghetti F; Vizzardi E; Elmaghawry M; Mamedouv R; D'Aloia A; Bonadei I; Sciatti E; Lipari A; Cerini M; Bontempi L; Metra M; Curnis A
    Recent Pat Cardiovasc Drug Discov; 2013 Dec; 8(3):204-15. PubMed ID: 24359232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
    Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA
    J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiarrhythmic drug therapy and catheter ablation in patients with paroxysmal or persistent atrial fibrillation: a systematic review and meta-analysis.
    Chander S; Kumari R; Luhana S; Shiwlani S; Parkash O; Sorath F; Wang HY; Tan S; Rahaman Z; Mohammed YN; Lohana AC; Sakshi F; Vaish E; Sadarat F
    BMC Cardiovasc Disord; 2024 Jun; 24(1):321. PubMed ID: 38918704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twelve-year follow-up of catheter ablation for atrial fibrillation: A prospective, multicenter, randomized study.
    Bertaglia E; Senatore G; De Michieli L; De Simone A; Amellone C; Ferretto S; La Rocca V; Giuggia M; Corrado D; Zoppo F; Stabile G
    Heart Rhythm; 2017 Apr; 14(4):486-492. PubMed ID: 27989681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal energy requirement for external cardioversion and catheter ablation for long-standing persistent atrial fibrillation.
    Kim IS; Kim TH; Yang PS; Uhm JS; Joung B; Lee MH; Pak HN
    J Cardiol; 2017 Jan; 69(1):162-168. PubMed ID: 26987790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy.
    Yi F; Hou W; Zhou C; Yin Y; Lu S; Duan C; Cao M; Li M; Toft ES; Zhang H
    J Cardiovasc Pharmacol; 2019 Apr; 73(4):241-247. PubMed ID: 30688797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial fibrillation and the risk of ischaemic strokes or intracranial haemorrhages: comparisons of the catheter ablation, medical therapy, and non-atrial fibrillation population.
    Kim M; Yu HT; Kim J; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
    Europace; 2021 Apr; 23(4):529-538. PubMed ID: 33045047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Asad ZUA; Yousif A; Khan MS; Al-Khatib SM; Stavrakis S
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007414. PubMed ID: 31431051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What role for antiarrhythmic drugs today in patients with recurrent atrial fibrillation without relevant heart disease?].
    Alboni P
    G Ital Cardiol (Rome); 2015 Nov; 16(11):617-24. PubMed ID: 26571475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postprocedural antiarrhythmic drug therapy with bepridil on maintaining sinus rhythm after catheter ablation for persistent atrial fibrillation.
    Kondo T; Miake J; Kato M; Ogura K; Iitsuka K; Yamamoto K
    J Cardiol; 2016 Sep; 68(3):229-35. PubMed ID: 26654806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.